Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Oxford BioMedica
Biotech
Cerevel swaps CEO—Chutes & Ladders
Cerevel CEO to step down after four-year run. Day One revamps C-suite. Former Iovance CEO and VC partner jumps to Lassen.
Gabrielle Masson
,
Max Bayer
May 5, 2023 9:30am
New CEO will lead Teva at top of new year—Chutes & Ladders
Dec 2, 2022 9:30am
As CEO goes, cash woes drive Sio to throw Parkinson's program
Feb 1, 2022 7:05am
Homology scratches cash itch with $130M deal to fund trials
Jan 28, 2022 8:00am
Sanofi returns rights to gene therapies to Oxford Biomedica
Jun 8, 2020 12:17pm
Microsoft partners with biotech on ‘biological computing’
Mar 12, 2019 10:31am
